 |
Size ($ in 1000's)
At 12/31/2023: $542,023
At 09/30/2023: $354,832
Affinity Asset Advisors LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Affinity Asset Advisors LLC 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, below is a summary of the Affinity Asset Advisors LLC top holdings by largest position size, as per the latest 13f filing made by Affinity Asset Advisors LLC.
In the Affinity Asset Advisors LLC-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares
held by Affinity Asset Advisors LLC in that top holding, then the share count change between reporting periods, and finally the Affinity Asset Advisors LLC top holding position size
for that row.
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
|---|
| IMMUNOGEN INC |
1,404,608 |
+1,404,608 |
$41,647 | | IMGN | 1,404,608 | +1,404,608 | $41,647 |  TEVA PHARMACEUTICAL INDS LTD |
|
|
$34,452 | | TEVA | 1,900,000 | -100,000 | $19,836 | | Call | 1,400,000 | +300,000 | $14,616 | | CEREVEL THERAPEUTICS HLDNG I |
750,000 |
+64,939 |
$31,800 | | CERE | 750,000 | +64,939 | $31,800 | | CYMABAY THERAPEUTICS INC |
1,090,441 |
-38,935 |
$25,756 | | CBAY | 1,090,441 | -38,935 | $25,756 | | BRIDGEBIO PHARMA INC |
|
|
$23,808 | | NOTE 2 | 17,000,000 | UNCH | $20,578 | | BBIO | 80,000 | +50,000 | $3,230 | | MADRIGAL PHARMACEUTICALS INC |
100,000 |
+15,000 |
$23,138 | | MDGL | 100,000 | +15,000 | $23,138 | | XENON PHARMACEUTICALS INC |
460,000 |
+159,562 |
$21,188 | | XENE | 460,000 | +159,562 | $21,188 | | ARCELLX INC |
340,000 |
-60,000 |
$18,870 | | ACLX | 340,000 | -60,000 | $18,870 | | LIANBIO |
3,779,694 |
+3,107,337 |
$16,895 | | LIAN | 3,779,694 | +3,107,337 | $16,895 | | CELLDEX THERAPEUTICS INC NEW |
400,000 |
+250,000 |
$15,864 | | CLDX | 400,000 | +250,000 | $15,864 | | APOGEE THERAPEUTICS INC |
537,093 |
-508,017 |
$15,006 | | APGE | 537,093 | -508,017 | $15,006 | | IMMUNOVANT INC |
345,000 |
+173,100 |
$14,535 | | IMVT | 345,000 | +45,000 | $14,535 | | CYTOKINETICS INC |
160,000 |
-70,366 |
$13,358 | | CYTK | 160,000 | -70,366 | $13,358 | | NUVALENT INC |
175,000 |
+125,000 |
$12,878 | | NUVL | 175,000 | +125,000 | $12,878 | | CRINETICS PHARMACEUTICALS IN |
|
|
$12,553 | | CRNX | 447,095 | -2,905 | $15,908 | | Put | 94,300 | +94,300 | $3,355 | | ESTABLISHMENT LABS HLDGS INC |
|
|
$11,735 | | ESTA | 228,277 | -10,831 | $5,910 | | Call | 225,000 | +85,000 | $5,825 | | ASTRIA THERAPEUTICS INC |
1,466,465 |
+466,165 |
$11,262 | | ATXS | 1,466,465 | +466,165 | $11,262 | | VERONA PHARMA PLC |
563,824 |
+195,495 |
$11,209 | | VRNA | 563,824 | +195,495 | $11,209 | | AUTOLUS THERAPEUTICS PLC |
1,550,408 |
-442,058 |
$9,985 | | AUTL | 1,550,408 | -442,058 | $9,985 | | ALKERMES PLC |
|
|
$9,137 | | ALKS | 356,384 | +256,384 | $9,886 | | Put | 27,000 | +27,000 | $749 | | INOZYME PHARMA INC |
1,885,802 |
+505,950 |
$8,034 | | INZY | 1,885,802 | +505,950 | $8,034 | | NURIX THERAPEUTICS INC |
690,112 |
+440,112 |
$7,122 | | NRIX | 690,112 | +440,112 | $7,122 | | CENTESSA PHARMACEUTICALS PLC |
795,729 |
-222,362 |
$6,334 | | CNTA | 795,729 | -222,362 | $6,334 | | SPYRE THERAPEUTICS INC |
517,554 |
+275,257 |
$6,216 | | AGLE | 517,554 | +275,257 | $6,216 | | APELLIS PHARMACEUTICALS INC |
|
|
$5,986 | | APLS | 75,000 | +35,000 | $4,490 | | Call | 25,000 | +25,000 | $1,496 | | MIRATI THERAPEUTICS INC |
100,049 |
+39,623 |
$5,878 | | MRTX | 100,049 | +39,623 | $5,878 | | ALNYLAM PHARMACEUTICALS INC |
|
|
$5,742 | | Call | 30,000 | +30,000 | $5,742 | | ROIVANT SCIENCES LTD |
500,000 |
+350,000 |
$5,615 | | ROIV | 500,000 | +350,000 | $5,615 | | VIKING THERAPEUTICS INC |
300,000 |
+332,600 |
$5,583 | | VKTX | 300,000 | UNCH | $5,583 | | SAVARA INC |
1,150,000 |
UNCH |
$5,405 | | SVRA | 1,150,000 | UNCH | $5,405 | | COMPASS PATHWAYS PLC |
550,000 |
+550,000 |
$4,812 | | CMPS | 550,000 | +550,000 | $4,812 | | MOONLAKE IMMUNOTHERAPEUTICS |
70,988 |
+20,988 |
$4,287 | | MLTX | 70,988 | +20,988 | $4,287 | | DYNAVAX TECHNOLOGIES CORP |
300,000 |
+100,000 |
$4,194 | | DVAX | 300,000 | +100,000 | $4,194 | | STRUCTURE THERAPEUTICS INC |
|
|
$4,076 | | Call | 100,000 | +100,000 | $4,076 | | ASTRAZENECA PLC |
60,000 |
UNCH |
$4,041 | | AZN | 60,000 | UNCH | $4,041 | | AXSOME THERAPEUTICS INC |
50,000 |
+50,000 |
$3,980 | | AXSM | 50,000 | +50,000 | $3,980 | | SPRINGWORKS THERAPEUTICS INC |
100,000 |
+58,419 |
$3,650 | | SWTX | 100,000 | +58,419 | $3,650 | | OMEROS CORP |
|
|
$3,600 | | NOTE 5 | 6,000,000 | +6,000,000 | $3,600 | | COHERUS BIOSCIENCES INC |
|
|
$3,403 | | NOTE 1 | 6,000,000 | +6,000,000 | $3,403 | | RELAY THERAPEUTICS INC |
300,000 |
+300,000 |
$3,303 | | RLAY | 300,000 | +300,000 | $3,303 | | KRYSTAL BIOTECH INC |
25,000 |
-32,500 |
$3,102 | | KRYS | 25,000 | -32,500 | $3,102 | | CULLINAN ONCOLOGY INC |
300,000 |
+300,000 |
$3,057 | | CGEM | 300,000 | +300,000 | $3,057 | | TANGO THERAPEUTICS INC |
300,274 |
-49,726 |
$2,973 | | TNGX | 300,274 | -49,726 | $2,973 | | ARGENX SE |
7,500 |
+7,500 |
$2,853 | | ARGX | 7,500 | +7,500 | $2,853 | | KURA ONCOLOGY INC |
191,535 |
-665,000 |
$2,754 | | KURA | 191,535 | -665,000 | $2,754 | | CASSAVA SCIENCES INC |
|
|
$2,724 | | Call | 121,000 | +121,000 | $2,724 | | ASCENDIS PHARMA A S |
20,000 |
-26,400 |
$2,519 | | ASND | 20,000 | -26,400 | $2,519 | | MERSANA THERAPEUTICS INC |
1,000,000 |
-1,850,000 |
$2,320 | | MRSN | 1,000,000 | -1,850,000 | $2,320 | | IMMATICS N.V |
200,000 |
UNCH |
$2,106 | | IMTX | 200,000 | UNCH | $2,106 | | PENUMBRA INC |
7,500 |
+7,500 |
$1,887 | | PEN | 7,500 | +7,500 | $1,887 |
See Full List: All Stocks Held By Affinity Asset Advisors LLC
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By Affinity Asset Advisors LLC
|
|
